Get Glyxambi Online

Glyxambi is a prescription combination tablet containing empagliflozin and linagliptin. Empagliflozin is an SGLT2 inhibitor that causes the kidneys to remove excess glucose through urine. Linagliptin is a DPP-4 inhibitor that increases insulin release in response to meals and lowers excess glucagon levels. Together they address blood sugar from two different angles in a single daily dose.

Glyxambi is approved for adults with type 2 diabetes who need additional blood sugar control beyond what a single oral medication provides. It is not approved for type 1 diabetes and should not be used in people with severe kidney impairment or a history of serious hypersensitivity to either component. A licensed physician will review your full health history before prescribing.

Common side effects include urinary tract infections, genital yeast infections, and increased urination, which are associated with the SGLT2 inhibitor component. Upper respiratory tract infections and nasopharyngitis are also frequently reported. Rare but serious risks include diabetic ketoacidosis, Fournier's gangrene, and a significant drop in blood pressure, particularly in people who are dehydrated or on diuretics.

Glyxambi is taken orally once daily in the morning, with or without food. The tablet comes in two strengths (10 mg/5 mg and 25 mg/5 mg). Your physician will determine the appropriate starting dose based on your current medications, kidney function, and blood sugar control goals. Do not split or crush the tablet.

Yes. Glyxambi is commonly used as an add-on to other diabetes medications such as metformin or insulin. However, combining it with insulin or insulin secretagogues may increase the risk of low blood sugar. Your physician will review all your current medications to ensure the combination is safe and effective.

Yes. Your physician will typically check kidney function (eGFR and serum creatinine) before starting Glyxambi and periodically thereafter, since the empagliflozin component works through the kidneys and is less effective at lower kidney function levels. Regular HbA1c testing is also recommended to track blood sugar control over time.

Doctronic uses an AI-powered evaluation to gather your symptoms, medical history, and current medications. A licensed physician then reviews your information and, if appropriate, creates a personalized treatment plan that may include a Glyxambi prescription. The entire process is HIPAA-aligned and conducted by board-certified physicians.

Yes. Doctronic is a telehealth platform staffed by licensed physicians whose prescribing decisions are doctor-reviewed and regularly audited for quality and safety. All patient data is protected under HIPAA. Doctronic serves adults 18 and older in any U.S. state.